Cross border, highly individualised treatment of a patient with challenging extensively drug-resistant tuberculosis.
Akkerman OW, Grasmeijer F, de Lange WCM, Kerstjens HAM, de Vries G, Bolhuis MS, Alffenaar JW, Frijlink HW, Smith G, Gajraj R, de Zwaan R, Hagedoorn P, Dedicoat M, van Soolingen D, van der Werf TS.
Akkerman OW, et al. Among authors: frijlink hw.
Eur Respir J. 2018 Mar 22;51(3):1702490. doi: 10.1183/13993003.02490-2017. Print 2018 Mar.
Eur Respir J. 2018.
PMID: 29419442
Free PMC article.